Shanghai International Exhibition on Ophthalmology and Optometry Technologies and Equipment

The Exhibition Value of the Shanghai International Ophthalmology Expo

• COOC Shanghai Ophthalmology Expo is the largest and most influential event in the Asia-Pacific region that seamlessly integrates ophthalmic science with industry. Having been successfully held for more than twenty consecutive editions, it is widely recognized within the industry as a leading indicator for China’s ophthalmology and optometry sectors, as well as a central platform for translating global eye‑care technologies into practical applications. Organized by authoritative bodies such as the Ophthalmology Branch of the Chinese Research Hospital Association, the expo takes place annually in Shanghai. Leveraging the city’s strategic position as a medical hub of the Yangtze River Delta and an international metropolis, it has become a pivotal platform for connecting global resources across the eye‑care value chain, showcasing cutting-edge technological advances, and shaping industry trends.
• The core value of exhibiting lies in its unparalleled dual‑driven “academic + industrial” platform and its robust channels for precisely reaching professional buyers. The expo brings together ophthalmic experts, emerging talents, and industry-leading enterprises from around the world. Through keynote speeches, high‑level forums, and other formats, it highlights major clinical breakthroughs in ophthalmology and visual sciences, both domestically and internationally—making it an essential annual gathering for ophthalmologists, optometrists, distributors, and procurement decision‑makers at healthcare institutions. The event features carefully curated thematic zones and activities, continuously expanding the optometry exhibition area to include refractive‑error testing equipment, vision‑training devices and systems, AI‑powered diagnostic tools, orthokeratology lenses, eye‑care products, optometry chain networks, and optometry training programs, thereby providing exhibitors with a strategic gateway directly to key purchasing decision‑makers.
• The expo has established a one‑stop commercial platform covering the entire eye‑care value chain. Exhibits span all categories, including ophthalmic diagnostic equipment (fundus cameras, OCT scanners, surgical microscopes), optometric testing instruments (refractors, biometers), myopia‑control products (orthokeratology lenses, defocus lenses, atropine eye drops), AI‑based screening systems, vision‑function training devices, eye‑care products, surgical instruments, and consumables—covering everything from clinical diagnostics to patient management, and from medical devices to consumer‑grade products, thus forming a complete industrial ecosystem closed loop.
• The expo aligns closely with three major industry trends—artificial intelligence, myopia control, and precision medicine—creating a high‑tech hub deeply integrating research, education, industry, and application. As AI technology increasingly empowers the field of ophthalmology, Eagle Eye Technology unveiled its next‑generation AI‑enabled fundus camera, the AFC‑100, featuring a jaw‑free tilting design and a 2/3‑inch imaging sensor. This device delivers non‑invasive, highly efficient fundus image analysis, particularly suited for adolescent myopia prevention and diabetic retinopathy monitoring. Myopia control emerged as a central theme throughout the event: Nidec, a pioneer in long‑range myopia‑control technology, showcased its full range of freeform optical solutions, generating high‑resolution images up to 6 meters away on a 151‑inch display, addressing the root causes underlying the onset and progression of myopia. Essilor’s XtraVue Control released results from a six‑year clinical trial demonstrating that continuous wear of its advanced aspheric lenses delayed myopia progression by an average of 1.95 diopters and slowed axial elongation by an average of 0.81 millimeters compared to single‑vision lenses.
• A rich array of concurrent events creates a premier platform for industry dialogue. During the expo, numerous academic forums, new‑product launch events, and technical exchange sessions are held, focusing on pressing topics such as myopia control, AI applications in ophthalmology, and cutting‑edge developments in eye‑care technology. Professor Li Shiming from Beijing Tongren Hospital, affiliated with Capital Medical University, urged greater attention to the utilization of hyperopic reserve, advocating tiered management based on individual hyperopic reserve reference values to achieve more precise and effective myopia management. Meanwhile, Professor He XianGui from the Shanghai Eye Disease Prevention and Treatment Center emphasized the critical importance of early intervention to slow the progression of myopia and prevent its occurrence among high‑risk populations, underscoring the significance of comprehensive myopia prevention strategies.
• For Chinese enterprises, this expo serves as a strategic gateway for expanding into the domestic market, connecting with global resources, and showcasing innovative capabilities. With an overall childhood and adolescent myopia prevalence rate of 51.9% in China—36.7% among primary school students, 71.4% among junior high school students, and 81.2% among senior high school students—myopia control has become a national priority. The expo gathers traditional lens giants such as Zeiss Optics, Essilor, and Mingyue Lenses, renowned pharmaceutical companies like Xingqi Eye Medicine and Hailu, as well as smart‑technology innovators like Eagle Eye Technology, Nidec, and BOE Health, collectively sharing personalized solutions tailored to different age groups and application scenarios. Exhibiting companies can leverage this platform to connect with domestic medical and optometric distribution channels, seizing the opportunity to lead the transformation of the eye‑care industry toward intelligence, precision, and consumer‑oriented innovation.